BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16673297)

  • 1. Current issues and future directions in treatment.
    Hui CK; Lau GK
    Semin Liver Dis; 2006 May; 26(2):192-7. PubMed ID: 16673297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment.
    Feld JJ; Heathcote EJ
    Semin Liver Dis; 2006 May; 26(2):116-29. PubMed ID: 16673290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.
    Hadziyannis SJ; Papatheodoridis GV
    Semin Liver Dis; 2006 May; 26(2):130-41. PubMed ID: 16673291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis B: a wider range of therapeutic options.
    Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
    Fung J; Lai CL; Yuen MF
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B.
    Xu XW; Chen YG
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):350-9. PubMed ID: 16911930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B: who to treat and which choice of treatment?
    Di Marco V; Craxì A
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF
    Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus serology to predict antiviral response in chronic hepatitis B.
    Kim BK; Han KH; Ahn SH
    Digestion; 2011; 84 Suppl 1():29-34. PubMed ID: 22156483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Customizing the management of chronic hepatitis B virus infection.
    Gish RG; Perrillo RP; Jacobson IM
    Semin Liver Dis; 2007 Aug; 27 Suppl 1():9-17. PubMed ID: 17701845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hepatitis B--who should be treated?
    Coffin CS; Lee SS
    MedGenMed; 2006 Mar; 8(1):75. PubMed ID: 16915205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies for chronic hepatitis B virus infection in 2008.
    Khokhar A; Afdhal NH
    Am J Med; 2008 Dec; 121(12 Suppl):S33-44. PubMed ID: 19185073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral therapy of chronic hepatitis B.
    Zoulim F
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic hepatitis B: antiviral treatment guidelines].
    Hézode C; Pawlotsky JM
    Rev Prat; 2010 Jun; 60(6):751-8. PubMed ID: 20623887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of chronic hepatitis B: 2009 update.
    Morgan M; Keeffe EB
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):5-22. PubMed ID: 19212304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
    Liaw YF
    Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
    Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing management strategies in special patient populations.
    Sherman M
    Am J Gastroenterol; 2006; 101 Suppl 1():S26-31. PubMed ID: 16448449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.